Drug resistance analysis of Mycoplasma Pneumoniae
- Analysis
- b3d78027e5b2
- 2025-06-26 14:04:12
Click the sample name to view the detailed results.
| Taxonomy | Distance |
|---|
- Sample: Strain name
- A2063G: 1 indicates presence of an A→G substitution at position 2063 in the M129-B7 reference strain; 0 indicates absence of this mutation.
- A2064G: 1 indicates presence of an A→G substitution at position 2064 in the M129-B7 reference strain; 0 indicates absence of this mutation.
- A2067G: 1 indicates presence of an A→G substitution at position 2067 in the M129-B7 reference strain; 0 indicates absence of this mutation.
- C2617G: 1 indicates presence of an C→G substitution at position 2617 in the M129-B7 reference strain; 0 indicates absence of this mutation.
- TYPE: When the TYPE column is marked as false, it indicates successful species identification; however, no mutations were detected at positions 2063, 2064, 2067, or 2617 of the M129-B7 reference strain.
If you use this tool in your research, please cite following reference:
TracePatho. 2025. TracePatho: All-in-one microbial analysis platform. Accessed July 9, 2025. https://tracepatho.com/.
Sun Y, Li P, Jin R, Liang Y, Yuan J, Lu Z, et al. Characterizing the epidemiology of Mycoplasma pneumoniae infections in China in 2022–2024: a nationwide cross-sectional study of over 1.6 million cases. J Abbrev. 2025;14(1).doi: 10.1080/22221751.2025.2482703.
Wang YS, Zhou YL, Bai GN, et al. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2024;20(9):901-914. doi:10.1007/s12519-024-00831-0